A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders
Eric Hollander, M.D.; Latha Soorya, Ph.D.; William Chaplin, Ph.D.; Evdokia Anagnostou, M.D.; Bonnie P. Taylor, Ph.D.; Casara J. Ferretti, M.S.; Stacey Wasserman, M.D.; Erika Swanson, M.A.; Cara Settipani, B.A.
From the Autism and Obsessive-Compulsive Spectrum Program, Department of Psychiatry and Behavioral Sciences, Albert Einstein College of Medicine and the Montefiore Medical Center, New York; and the Seaver Autism Center for Research and Treatment, Department of Psychiatry, Mount Sinai School of Medicine, New York.
Am J Psychiatry 2012;169:292-299.
doi:10.1176/appi.ajp.2011.10050764
Purchase Online access to this article for 24 hours
Clicking on the buy now link will redirect you to the shopping cart at APPI.org where you will be asked to log in or create an account to complete your transaction. Once your transaction is complete, you will receive an email with instructions for accessing this content online and in PDF format.
You may view, download, and/or print the article for your personal, scholarly, research, and educational use. You may not (i) distribute a copy
(electronic or otherwise) of the article without the written permission of APA, (ii) post the article on an electronic bulletin board or web
site, or (iii) charge for a copy (electronic or otherwise) of the article.